AZD6750 + Rilvegostomig

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

AZD6750 + Rilvegostomig
Treatment and conditionWhere it standsTrials
AZD6750 + Rilvegostomig for squamous cell carcinoma of head and neckPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1